Joshua W. Tashman

Joshua W. Tashman

Auto-generated profile, based on publicly available information

Joshua W. Tashman

Department of Biomedical Engineering, Carnegie Mellon University, Pittsburgh, PA 15213, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2019 in Science
Verified
Journal Article
Closed access
PDF file
ALA. Lee
A. Lee
AHA. R. Hudson
A. R. Hudson
DSDaniel J. Shiwarski
Daniel J. Shiwarski
JTJ. W. Tashman
J. W. Tashman
THT. J. Hinton
T. J. Hinton
AFAdam Walter Feinberg
Adam Walter Feinberg
If I only had a heart: 3D bioprinting is still a fairly new technique that has been limited in terms of resolution and by the materials that can be printed. Lee et al. describe a 3D printing technique to build complex collagen scaffolds for engineering biological tissues (see the Perspective by Dasgupta and Black). Collagen gelation was controlled by modulation of pH and could provide up to 10-micrometer resolution on printing. Cells could be embedded in the collagen or pores could be introduced into the scaffold via embedding of gelatin spheres. The authors demonstrated successful 3D printing of five components of the human heart spanning capillary to full-organ scale, which they validated for tissue and organ function. Science , this issue p. 482 ; see also p. 446

2 August 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
AKAnna Kalmykov
Anna Kalmykov
Changjin HuangChangjin Huang
Changjin Huang
JBJacqueline Bliley
Jacqueline Bliley
DSDaniel J. Shiwarski
Daniel J. Shiwarski
JTJoshua Tashman
Joshua Tashman
TCTzahi Cohen-Karni
Tzahi Cohen-Karni
An organ-on-electronic chip (organ-on-e-chip)—a three-dimensional (3D) biosensor array to decipher tissue electrical activity.

16 February 2021 in APL Bioengineering
Verified
Journal Article
Open access
PDF file
DSDaniel J. Shiwarski
Daniel J. Shiwarski
AHAndrew R. Hudson
Andrew R. Hudson
JTJoshua W. Tashman
Joshua W. Tashman
AFAdam Walter Feinberg
Adam Walter Feinberg
In tissue engineering, an unresolved challenge is how to build complex 3D scaffolds in order to recreate the structure and function of human tissues and organs. Additive manufacturing techniques, such as 3D bioprinting, have the potential to build biological material with unprecedented spatial control; however, printing soft biological materials in air often results in poor fidelity. Freeform Reversible Embedding of Suspended Hydrogels (FRESH) is an embedded printing approach that solves this problem by extruding bioinks within a yield-stress support bath that holds the bioinks in place until cured. In this Perspective, we discuss the challenges of 3D printing soft and liquid-like bioinks and the emergence for FRESH and related embedded printing techniques as a solution. This includes the development of FRESH and embedded 3D printing within the bioprinting field and the rapid growth in adoption, as well as the advantages of FRESH printing for biofabrication and the new research results this has enabled. Specific focus is on the customizability of the FRESH printing technique where the chemical composition of the yield-stress support bath and aqueous phase crosslinker can all be tailored for printing a wide range of bioinks in complex 3D structures. Finally, we look ahead at the future of FRESH printing, discussing both the challenges and the opportunities that we see as the biofabrication field develops.

21 July 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
JBJacqueline M. Bliley
Jacqueline M. Bliley
MVMathilde Vermeer
Mathilde Vermeer
RDRebecca M. Duffy
Rebecca M. Duffy
IBIvan Batalov
Ivan Batalov
DKDuco Kramer
Duco Kramer
AFAdam Walter Feinberg
Adam Walter Feinberg
A dynamic mechanical loading platform was developed to improve contractility of engineered heart tissues and study cardiac disease progression.

25 April 2025 in Science Advances
Verified
Journal Article
Open access
DSDaniel J. Shiwarski
Daniel J. Shiwarski
AHAndrew R. Hudson
Andrew R. Hudson
JTJoshua W. Tashman
Joshua W. Tashman
EBEzgi Bakirci
Ezgi Bakirci
SMSamuel Moss
Samuel Moss
AFAdam Walter Feinberg
Adam Walter Feinberg
Organ-on-a-chip and microfluidic systems have improved the translational relevance of in vitro systems; however, current manufacturing approaches impart limitations on materials selection, non-native mechanical properties, geometric complexity, and cell-driven remodeling into functional tissues. Here, we three-dimensionally (3D) bioprint extracellular matrix (ECM) and cells into collagen-based high-resolution internally perfusable scaffolds (CHIPS) that integrate with a vascular and perfusion organ-on-a-chip reactor (VAPOR) to form a complete tissue engineering platform. We improve the fidelity of freeform reversible embedding of suspended hydrogels (FRESH) bioprinting to produce a range of CHIPS designs fabricated in a one-step process. CHIPS exhibit size-dependent permeability of perfused molecules into the surrounding scaffold to support cell viability and migration. Lastly, we implemented multi-material bioprinting to control 3D spatial patterning, ECM composition, cellularization, and material properties to create a glucose-responsive, insulin-secreting pancreatic-like CHIPS with vascular endothelial cadherin + vascular-like networks. Together, CHIPS and VAPOR form a platform technology toward engineering full organ-scale function for disease modeling and cell replacement therapy.

16 March 2022 in Biofabrication
Verified
Journal Article
Closed access
JBJacqueline Bliley
Jacqueline Bliley
JTJoshua Tashman
Joshua Tashman
MSMaria Stang
Maria Stang
BCBrian Coffin
Brian Coffin
DSDaniel J. Shiwarski
Daniel J. Shiwarski
AFAdam Walter Feinberg
Adam Walter Feinberg
Here we report the 3D bioprinting of a simplified model of the heart, similar to that observed in embryonic development, where the heart is a linear tube that pumps blood and nutrients to the growing embryo. To this end, we engineered a bioinspired model of the human heart tube using freeform reversible of embedding of suspended hydrogels 3D bioprinting. The 3D bioprinted heart tubes were cellularized using human stem cell-derived cardiomyocytes and cardiac fibroblasts and formed patent, perfusable constructs. Synchronous contractions were achieved ∼3–4 days after fabrication and were maintained for up to a month. Immunofluorescent staining confirmed large, interconnected networks of sarcomeric alpha actinin-positive cardiomyocytes. Electrophysiology was assessed using calcium imaging and demonstrated anisotropic calcium wave propagation along the heart tube with a conduction velocity of ∼5 cm s −1 . Contractility and function was demonstrated by tracking the movement of fluorescent beads within the lumen to estimate fluid displacement and bead velocity. These results establish the feasibility of creating a 3D bioprinted human heart tube and serve as an initial step towards engineering more complex heart muscle structures.